Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 2
2005 3
2006 3
2007 2
2008 5
2009 1
2010 2
2011 3
2012 2
2013 6
2014 1
2015 4
2016 2
2017 2
2018 4
2020 5
2021 7
2022 2
2023 5
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

57 results

Results by year

Filters applied: . Clear all
Page 1
Metastatic Melanoma: Liquid Biopsy as a New Precision Medicine Approach.
Ricciardi E, Giordani E, Ziccheddu G, Falcone I, Giacomini P, Fanciulli M, Russillo M, Cerro M, Ciliberto G, Morrone A, Guerrisi A, Valenti F. Ricciardi E, et al. Among authors: giacomini p. Int J Mol Sci. 2023 Feb 16;24(4):4014. doi: 10.3390/ijms24044014. Int J Mol Sci. 2023. PMID: 36835424 Free PMC article. Review.
[Corrigendum] TOOLBOX: Strep‑Tagged nano‑assemblies of antibody‑drug‑conjugates (ADC) for modular and conditional cancer drugging.
Tremante E, Sibilio L, Centola F, Knutti N, Holzapfel G, Manni I, Allegretti M, Lombardi P, Salvo G, Cecchetelli L, Friedrich K, Bertram J, Giacomini P. Tremante E, et al. Among authors: giacomini p. Oncol Rep. 2021 Aug;46(2):159. doi: 10.3892/or.2021.8110. Epub 2021 Jul 15. Oncol Rep. 2021. PMID: 34261292 Free PMC article.
Bridging therapeutic opportunities: a survey by the Italian molecular tumor board workgroup of Alliance Against Cancer.
Ciliberto G, Canfora M, Terrenato I, Agnoletto C, Agustoni F, Amoroso L, Baldassarre G, Curigliano G, Delmonte A, De Luca A, Fiorentino M, Gregorc V, Ibrahim T, Lazzari C, Mastronuzzi A, Pronzato P, Santoro A, Scambia G, Tommasi S, Vingiani A, Giacomini P, De Maria R. Ciliberto G, et al. Among authors: giacomini p. J Exp Clin Cancer Res. 2022 Oct 17;41(1):305. doi: 10.1186/s13046-022-02512-0. J Exp Clin Cancer Res. 2022. PMID: 36245005 Free PMC article.
The Molecular Tumor Board of the Regina Elena National Cancer Institute: from accrual to treatment in real-world.
Giacomini P, Valenti F, Allegretti M, Pallocca M, De Nicola F, Ciuffreda L, Fanciulli M, Scalera S, Buglioni S, Melucci E, Casini B, Carosi M, Pescarmona E, Giordani E, Sperati F, Jannitti N, Betti M, Maugeri-Saccà M, Cecere FL, Villani V, Pace A, Appetecchia M, Vici P, Savarese A, Krasniqi E, Ferraresi V, Russillo M, Fabi A, Landi L, Minuti G, Cappuzzo F, Zeuli M, Ciliberto G. Giacomini P, et al. J Transl Med. 2023 Oct 16;21(1):725. doi: 10.1186/s12967-023-04595-5. J Transl Med. 2023. PMID: 37845764 Free PMC article.
T and NK cells: two sides of tumor immunoevasion.
Fruci D, Lo Monaco E, Cifaldi L, Locatelli F, Tremante E, Benevolo M, Giacomini P. Fruci D, et al. Among authors: giacomini p. J Transl Med. 2013 Feb 4;11:30. doi: 10.1186/1479-5876-11-30. J Transl Med. 2013. PMID: 23379575 Free PMC article.
Molecular Tumor Boards: On the evolution of species.
Giacomini P, Ciliberto G. Giacomini P, et al. Eur J Cancer. 2024 Apr;201:113910. doi: 10.1016/j.ejca.2024.113910. Epub 2024 Feb 13. Eur J Cancer. 2024. PMID: 38382152 No abstract available.
57 results